Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up
30 Years
N/A
Female
Breast Cancer
Trial Information
Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up
Disparities in incidence and mortality between African Americans and Caucasians for a number
of cancers have been well documented. This study builds on previous work in St. Louis to
overcome barriers to access to breast screening, identifying and addressing factors
associated with access to care once diagnosed, and factors contributing to delay in
diagnosis and completion of therapy. African American breast cancer patients randomly
assigned to the intervention arm of the trial will have access to the Survivor Stories
Tablet, a tablet computer, on which they will browse an archive of 1-3 minute videotaped
survivor stories about five topics: coping, relationships, experiences with the health care
system, follow-up care, and quality of life (QOL) living with breast cancer. Patients will
have the tablet for two weeks after enrollment in the study, and again at 6 and 12 months.
Patients in the control arm will receive usual care.
Inclusion Criteria:
- African American women
- First primary ductal carcinoma in situ (DCIS) or stages I, II, or III invasive breast
cancer.
Exclusion Criteria:
- Prior DCIS or breast cancer diagnosis
- Stage IV or metastatic breast cancer
- Having received double mastectomy
- non-English speaking,
- Having known psychiatric or neurologic disorders
- Being cognitively impaired according to weighted error scores on the
Orientation-Memory-Concentration Test
- Being unwilling or unable to give consent
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Outcome Measure:
Determine to what extent African American breast cancer survivor stories affect various aspects of QOL, including depressed mood and concern about recurrence, among African American breast cancer patients following primary treatment.
Outcome Time Frame:
Outcome measures are assessed at five time points: baseline, one month following primary treatment surgery, 6 months, one year, and two years post surgery.
Safety Issue:
No
Principal Investigator
Donna B Jeffe, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Washington University School of Medicine
Authority:
United States: Institutional Review Board
Study ID:
000799
NCT ID:
NCT00929084
Start Date:
November 2009
Completion Date:
Related Keywords:
- Breast Cancer
- Race Disparities
- Breast Cancer
- Quality of Life
- Treatment Adherence
- Breast Neoplasms
Name | Location |
|---|---|
| Washington University School of Medicine | Saint Louis, Missouri 63110 |
